IRP Researchers Engage and Educate at Competition Finals
Wednesday, July 13, 2022
English is generally considered the ‘international language of science,’ since nearly all scientific papers are published in English. Yet, even to a native English speaker, scientists seem to be using another language entirely to talk about their research. Most Americans, after all, don’t know an ‘autophagosome’ from a ‘lysosome’ and would be hard-pressed to explain the difference between an ‘oocyst’ and a ’sporozoite.’
Fortunately, efforts like NIH’s annual Three-Minute Talks (TmT) competition are helping scientists learn how to communicate about their research in a manner that is much easier to understand. On June 30, after months spent whittling down dozens of competitors from across the IRP, 10 finalists raced against the clock to explain their work and its importance in a clear and compelling way.
Drug Candidate Could Slow Progression and Reduce Side Effects
Wednesday, June 15, 2022
If you know someone with Parkinson’s disease, you’re probably familiar with the progressive tremors and movement difficulties it causes. Unfortunately, the most common treatment for the disease — a drug called levodopa, or L-DOPA for short — can make some movement problems worse when taken for long periods of time. That’s why IRP senior investigator David R. Sibley, Ph.D., and postdoctoral fellow Amy Moritz, Ph.D., have taken on the challenge of discovering new drugs that could be given to patients in conjunction with existing treatments to more effectively slow the disease’s progression while reducing side effects.
Pushing Cells to Their Limits Could Enable Earlier Diagnosis and Treatment
Tuesday, March 29, 2022
If the many stories of mothers lifting cars to save their trapped children prove anything, it’s that we cannot know the true capabilities of our bodies until they are put to the test. This concept, it turns out, could be the key to much earlier diagnosis for Parkinson’s disease. By stimulating specific neurons to push them to their limits, IRP researchers were able to detect Parkinson’s in mice in its very early stages, opening up the possibility that a similar test could one day allow human patients to begin treatment before the disease has caused too much damage.
IRP Scientists Keep it Short and Sweet in Competition’s Final Round
Wednesday, July 7, 2021
Science is so closely associated with long, jargon-laden lectures that scientists like Neil deGrasse Tyson and the IRP’s own Anthony Fauci have become celebrities for their ability to explain complex scientific concepts in a succinct and understandable way. On June 25, 17 postbacs, graduate students, and postdocs from across NIH showcased their own communication chops in the final round of the IRP’s annual Three-Minute Talks (TmT) competition.
‘Silicon Valley Nobel’ Recognizes Groundbreaking Parkinson’s Disease Research
Tuesday, October 6, 2020
It can be easy to underestimate the value of so-called ‘basic science’ that doesn’t appear, upon first glance, to have clear therapeutic applications. One of the hidden strengths of this sort of work is its ability to link seemingly disparate areas of scientific inquiry by identifying commonalities between the structure or behavior of different biological molecules. By following these unexpected connections over the course of his career, IRP senior investigator Richard Youle, Ph.D., has made critical discoveries about Parkinson’s disease — research that this year earned him the prestigious Breakthrough Prize in Life Sciences.
Mouse Study Identifies Neurological Obstacle to Dietary Improvements
Tuesday, September 15, 2020
Every morning, thousands of Americans wake up intending to eat more healthfully, only to find themselves chowing down on a greasy burger at dinnertime. In addition to the many biological and socioeconomic obstacles to healthy eating, a salad can just plain seem unappealing compared to a plate of crispy fries. According to new IRP research, a high-fat diet can dramatically alter how the brain responds to food in ways that make a more wholesome meal less enticing and satisfying.
Tuesday, October 16, 2018
The recent spate of state laws legalizing marijuana for medical or recreational purposes has prompted concerns that increased marijuana use will boost the number of people who become dependent on and abuse the drug, a condition known as cannabis use disorder (CUD). Treating the growing number of patients with CUD will require a greater understanding of how chronic marijuana use can lead to addiction. New IRP research has revealed that star-shaped brain cells called astrocytes may play a role in the pleasurable effects of marijuana and contribute to the drug’s addictive properties.
Thursday, August 16, 2018
Upon entering the sunny foyer of the NIH’s Natcher Conference Center last Thursday, I was immediately struck by a burst of loud, excited chatter. As it always is on NIH’s annual Summer Poster Day, the building was filled with hundreds of high school and college students and the scientists, families, and friends who had turned out to see what these young men and women had spent the summer doing.
Tuesday, May 22, 2018
It might seem easy to blame your parents for the way you turned out; after all, they raised you and gave you all of your DNA. But, before throwing blame around, consider saving some for the place where you grew up. According to new IRP research, being raised in an urban environment can dramatically alter how your genes influence your brain.1
Tuesday, May 8, 2018
Most people experience anxiety at some point in their lives, whether it’s pre-speech jitters or sweaty palms when their plane takes off. While mild feelings of nervousness are completely normal and can even be beneficial, anxiety can also have negative repercussions if it causes somebody to completely avoid situations like social encounters or taking a flight to visit distant family.